These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32239705)

  • 1. PLS3 predicts poor prognosis in pancreatic cancer and promotes cancer cell proliferation via PI3K/AKT signaling.
    Xin Z; Li D; Mao F; Du Y; Wang X; Xu P; Li Z; Qian J; Yao J
    J Cell Physiol; 2020 Nov; 235(11):8416-8423. PubMed ID: 32239705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LHPP suppresses proliferation, migration, and invasion and promotes apoptosis in pancreatic cancer.
    Wu F; Chen Y; Zhu J
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32186702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of plastin-3 via copy number gain induces the epithelial-mesenchymal transition in circulating colorectal cancer cells.
    Sugimachi K; Yokobori T; Iinuma H; Ueda M; Ueo H; Shinden Y; Eguchi H; Sudo T; Suzuki A; Maehara Y; Mori M; Mimori K
    Ann Surg Oncol; 2014 Oct; 21(11):3680-90. PubMed ID: 24217791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc-finger protein 471 suppresses gastric cancer through transcriptionally repressing downstream oncogenic PLS3 and TFAP2A.
    Cao L; Wang S; Zhang Y; Wong KC; Nakatsu G; Wang X; Wong S; Ji J; Yu J
    Oncogene; 2018 Jun; 37(26):3601-3616. PubMed ID: 29610526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
    Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMEM158 promotes pancreatic cancer aggressiveness by activation of TGFβ1 and PI3K/AKT signaling pathway.
    Fu Y; Yao N; Ding D; Zhang X; Liu H; Ma L; Shi W; Zhu C; Tang L
    J Cell Physiol; 2020 Mar; 235(3):2761-2775. PubMed ID: 31531884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
    Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
    Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ITGA6 and RPSA synergistically promote pancreatic cancer invasion and metastasis via PI3K and MAPK signaling pathways.
    Wu Y; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu M; Jin H
    Exp Cell Res; 2019 Jun; 379(1):30-47. PubMed ID: 30894280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells.
    Tanouchi A; Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Kimura M; Watanabe R; Kohsaki T; Shimizu T; Saito M; Hanazaki K; Saibara T
    J Exp Clin Cancer Res; 2016 Dec; 35(1):190. PubMed ID: 27919290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
    Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
    J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Peptide Probe for Identification of PLS3-Expressed Cancer Cells.
    Shi F; Ma Y; Qian Y; Wang Y; Wang Z; Zhao M; Hu Z
    Anal Chem; 2019 Aug; 91(15):9640-9647. PubMed ID: 31293151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
    Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S
    J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells.
    Yasuda A; Sawai H; Takahashi H; Ochi N; Matsuo Y; Funahashi H; Sato M; Okada Y; Takeyama H; Manabe T
    Mol Cancer; 2006 Oct; 5():46. PubMed ID: 17044945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
    Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.
    Yuan J; Xu XJ; Lin Y; Chen QY; Sun WJ; Tang L; Liang QX
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):198-206. PubMed ID: 30657561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway.
    Xu X; Yu Y; Zong K; Lv P; Gu Y
    J Exp Clin Cancer Res; 2019 Dec; 38(1):497. PubMed ID: 31852504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
    Wu L; Zheng J; Chen P; Liu Q; Yuan Y
    Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA MEG3 had anti-cancer effects to suppress pancreatic cancer activity.
    Gu L; Zhang J; Shi M; Zhan Q; Shen B; Peng C
    Biomed Pharmacother; 2017 May; 89():1269-1276. PubMed ID: 28320094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.